logo

Neoleukin Therapeutics, Inc. (NLTX)



Trade NLTX now with
  Date
  Headline
6/1/2020 8:09:49 AM Neoleukin Therapeutics Appoints Erin Lavelle To Board
11/7/2018 9:18:53 AM Aquinox Q3 Net Loss $15.0 Mln Vs Net Loss $11.8 Mln Last Year
8/8/2018 6:16:57 AM Aquinox Q2 EPS $0.12 Vs Loss $0.59 Prior Year
6/27/2018 6:33:36 AM Aquinox Says Phase 3 LEADERSHIP 301 Clinical Trial Of Oral Rosiptor (AQX-1125) Failed To Meet Its Primary Endpoint
6/11/2018 9:06:53 AM Aquinox Pharma Begins ProShip Phase 2 Proof-of-Concept Clinical Trial Investigating Rosiptor In CP/CPPS
5/9/2018 9:01:12 PM Aquinox And Astellas Announce Licensing Agreement For Rosiptor In Asia-Pacific Region Incl Japan
5/8/2018 9:07:58 AM Aquinox Pharma Q1 Net Loss $14.6 Mln Vs. Net Loss Of $8.3 Mln Prior Year
2/9/2018 8:40:56 AM Aquinox Says Met Its Enrollment Threshold Of 300 Females In LEADERSHIP 301 Clinical Trial Of Rosiptor (AQX-1125)